The shortage and high cost of medicine is the result of the currency market and inflation
The vice-chairman of the health and treatment commission of the parliament considered the shortage and high cost of medicine to be the result of improper management of the currency market and inflation.
According to Ambassador Arjan, quoted by Khane Mellat, Ruhollah Lak Aliabadi, criticizing the continued shortage and increase in drug prices, said: "Despite the importance of supplying drugs and treating people, in the last one or two years we have been facing problems in the field of drug production and supply, and this situation must be resolved seriously."
Referring to the country's foreign exchange policies, he added: "The central bank enters the market with the aim of controlling the dollar rate, but this approach is subject to debate from an expert's point of view, because the main priorities of the country should be treatment, provision of people's livelihood and housing."
Emphasizing the need to pay attention to the health sector, Lak Aliabadi continued: If resources and policies are properly managed, an important part of people's problems in the field of treatment and medicine can be solved, but unfortunately, no effective action has been taken in this field.
Criticizing the performance of the government's economic team in controlling inflation and managing the currency market, the vice-chairman of the parliament's health and treatment committee stated: The central bank and the minister of economy have not acted as expected in managing the country's economic issues and curbing inflation.
He reminded: One of the main points of criticism of the Minister of Economy is the lack of sufficient management and planning to deal with inflation and organize the currency market. A topic whose effects can be seen in various sectors, including the field of medicine and treatment.
Referring to the continuation of pharmaceutical problems, Lak Aliabadi said: "Currently, we are facing both the shortage of some medicines and the increase in their prices, and so far no convincing answer has been received from the Central Bank to solve these problems."